Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowU.S. regulators incorrectly identified Eli Lilly and Co. as the manufacturer of Cialis pills banned from entering the United States for containing the active ingredient for rival erectile-dysfunction drug Viagra.
The Food and Drug Administration acknowledged the mistake Friday in an e-mail and said it removed Indianapolis-based Lilly’s name from an import alert that attributed the pills to the company’s office in Australia.
The FDA originally issued the ban earlier this week. Soon after, Indianapolis-based Lilly said it doesn’t operate a manufacturing site in Australia. The company said the product appears to be counterfeit.
“Eli Lilly, the manufacturer of Cialis tablets, is cooperating with FDA as we continue to look into this incident,” Christopher Kelly, a spokesman for the agency, said in the e-mail.
Please enable JavaScript to view this content.